Key result
Rheumatic mitral valve disease ventricular tissue exhibits slower depolarization and repolarization versus normal canine muscle.
Observational
May indicate remodeling in rheumatic mitral valve disease; leaves open whether species differences confound canine comparisons.
The human ventricular transmembrane action potential has been studied in small pieces of left ventricular papillary muscle removed from patients with rheumatic mitral valve disease at operation. The recordings obtained by a microelectrode technique have been compared with those obtained from normal canine papillary muscle. The findings are considered in the light of the disturbances in the environment of the human cardiac tissue produced by electrolyte disturbances and digoxin treatment. The human ventricular transmembrane action potential is, in general, similar to that of the normal dog. However, the rate of depolarisation and repolarisation of the human tissue is slower than that of the dog. Electrolyte disturbances do not seem sufficient to account for these changes but they may be due to the effect of digitalis treatment or the result of long-standing cardiac disease. A true species difference cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Coltart et al. (2008) conducted an observational in Rheumatic mitral valve disease. Human ventricular tissue (rheumatic mitral valve disease) vs. Normal canine papillary muscle was evaluated on Transmembrane action potential characteristics (rate of depolarisation and repolarisation). Human ventricular tissue from patients with rheumatic mitral valve disease exhibited slower rates of depolarisation and repolarisation compared to normal canine papillary muscle.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: